Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
RESEARCH TOOLSreports
Holding DE:FME?
Track your performance easily
FME Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€30.95 - €42.12
Previous Close€36.34
Volume136.15K
Average Volume (3M)320.77K
Market Cap
€10.66B
Enterprise Value€18.21B
Total Cash (Recent Filing)€1.56B
Total Debt (Recent Filing)€7.90B
Price to Earnings (P/E)19.9
Beta0.85
Next Earnings
Nov 05, 2024EPS Estimate
€0.71Last Dividend Ex-Date
May 17, 2024Dividend Yield3.34%
Share Statistics
EPS (TTM)1.81
Shares Outstanding293,413,449
10 Day Avg. Volume385,218
30 Day Avg. Volume320,772
Standard Deviation0.09
R-Squared0.15
Alpha-0.00408
Financial Highlights & Ratios
Price to Book (P/B)1.56
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€35.77Price Target Upside-2.17% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering7
Fresenius Medical Care AG & Co. KGaA News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceA growing US value-based care business had a beneficial effect on profitability.
Product LaunchFresenius Medical Care will launch its 5008X machine in 2025 in the US.
Product Line EnhancementHV HDF is a good addition to Fresenius’ product lineup, in terms of both health outcomes and financials results.
Bears Say
Financial TargetsFY 2025 targets remain a stretch as FME would need a significant uptick in profitability to achieve them.
Market PerformanceYear to date relative performance vs DAX shows a decrease of 10.4%, reflecting weaker market positioning.
Volume GrowthThe lack of volume recovery indicates a worse-than-expected underlying market health, challenging FME's future outlook.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
19.48% Mutual Funds
<0.01% Other Institutional Investors
74.20% Public Companies and
Individual Investors
FME FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest stock price was €30.95 and its highest was €42.12 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Currently, no data Available
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is Nov 05, 2024 which is in 3 days.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Jul 30, 2024. The company reported €0.7 earnings per share for the quarter, beating the consensus estimate of €0.68 by €0.02.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Overvalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.19 which represents an annual dividend yield of 3.34%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is €0.71.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.7 in its last earnings report, beating expectations of €0.68. Following the earnings report the stock price went down -4.514%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:FME
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
€35.77 (-2.17% Downside)
€35.77 (-2.17% Downside)
Insider Transactions
Bought Shares
Worth €455.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.46%
12-Months-Change
Fundamentals
Return on Equity
3.86%
Trailing 12-Months
Asset Growth
-3.04%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
FME Stock 12 Month Forecast
Average Price Target
€35.77
▼(-2.17% Downside)
Technical Analysis
Fresenius Medical Care AG & Co. KGaA
―
Hikma Pharmaceuticals
―
Genus plc
―
PureTech Health
―
Best Analysts Covering FME
1 Year
1 Year Success Rate
23/36 ratings generated profit
1 Year Average Return
+1.94%
reiterated a sell rating 8 days ago
Copying James Vane's trades and holding each position for 1 Year would result in 63.89% of your transactions generating a profit, with an average return of +1.94% per trade.
---